Gothenburg company partners up with international giant


Gothenburg medtech company Ortoma has signed a strategic alliance with DePuy Synthes, part of the multinational company Johnson & Johnson MedTech. The deal will help Ortoma to penetrate key markets, as it scales-up the commercialisation of its advanced surgery solution.

 The deal will allow Ortoma to integrate DePuy Synthes’ technology into the Ortoma Treatment Solution (OTS), a product used for orthopedic procedures, specifically for hip surgery. The system’s software, which is based on AI, enables improved accuracy, efficiency, and surgical results. The market launch is expected to take place in 2024.

“Ortoma is moving step by step towards global establishment of OTS and through our strategic collaboration we will be able to reach important markets such as the US and Europe,” said Linus Byström, CEO at Ortoma, in a statement. 

The Gothenburg company develops surgical systems for the planning and positioning of implants in hip, knee and spinal surgery. Matts Andersson, a pioneer in digitizing dentistry and an adjunct professor at Chalmers University of Technology in Gothenburg, is the founder and innovator behind Ortoma.  

“We have followed Ortoma’s journey since its inception in 2001 and are convinced that this collaboration will pave the way to new partnerships with key healthcare stakeholders. All with the ambition of obtaining better patient outcomes and fewer surgery complications – and thus allow for long-term survival and quality of life,” says Iris Öhrn, investment advisor for life science at Business Region Göteborg.

According to Byström, Ortoma plans to strengthen its commercialisation and delivery activities. At the same time, R&D remains a focus for the growing company. It has several other products in the pipeline, including a technology for converting 2D x-rays into 3D models to aid surgeons, which is receiving international recognition.   

“Our 2D/3D solution is groundbreaking and at the absolute forefront of technology with a great market potential,” says Byström. 

A proud tradition of ground-breaking innovation

One of Gothenburg’s key areas of expertise is in biomaterials and implants, including implants used in dentistry and orthopaedic surgery. This focus was driven by research from Professor Per-Ingvar Brånemark from the University of Gothenburg, who in the 1950s discovered and developed the science of osseointegration (the fusion of bone with implants), a key breakthrough in orthopaedics and dentistry. 

Nobel Biocare, a world-leading multinational company in restorative dentistry, grew from a combination of Brånemark’s osseointegration work and Matts Andersson's Procera method for the high-precision, repeatable production of dental implant crowns.

“Over the years, the academic and industrial actors in this field in Gothenburg have created a platform upon which world-leading research and applications have emerged. Traditions in knowledge-sharing and entrepreneurship have fostered strong ties between all players. Today, nearly half of all Swedish companies within biomaterials and implants reside in our region,” says Iris Öhrn.


Read more


We are here to help

Want to learn more about investment and partnering opportunities in Gothenburg and how we can help you tap into our life science ecosystem? Get in touch with our life science investment advisor Iris Öhrn ( // +46 (0)705260828).